The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Clinical Implications of Basic Research
PreviousPrevious
Volume 355:1611-1613 October 12, 2006 Number 15
NextNext

Amyotrophic Lateral Sclerosis — Are Microglia Killing Motor Neurons?
David R. Borchelt, Ph.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
Amyotrophic lateral sclerosis (ALS) is a disease characterized by the selective degeneration of motor neurons. The only known genetic cause of the disease, which accounts for about 2% of cases, is a mutation in the gene encoding superoxide dismutase 1 (SOD1) protein. Therefore, the effect of mutant SOD1 has been intensely studied, with emphasis on the question of whether it causes cell-autonomous degeneration of motor neurons or, rather, compromises the function of other types of cells in the spinal cord (such as astrocytes and microglia), which, in turn, damages neurons. A recent study by Boillee et al.1 sheds some light . . . [Full Text of this Article]


Source Information

From the Department of Neuroscience, McKnight Brain Institute, SantaFe Health Alzheimer's Disease Research Center, University of Florida, Gainesville.


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.